Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • jlynn
    Junior Member
    • Nov 2015
    • 3

    Help please- strange (and different) bioanalyzer results

    Hello Seq-answers community,

    I need help interpreting bioanalyzer results and the background is below:

    I have recently completed library prep using NEB next ultra ii DNA library kit for my ChIP-DNA samples. I made a mistake when diluting the adapters because I diluted them to my lowest concentrated sample and added the diluted adapters to all of my 6 samples even though some of them were at higher concentration and should have had 1/10 dilution of adapters rather than 1/25 (for low conc.). After figuring out why I had no DNA at the end of the lib prep, I was able to extract and clean up the DNA bound to the beads and from the supernatant containing size selected fragments that were not expected to be within the correct range. I then used the salvaged DNA to do another library prep, from end repair to the amplification of size selected fragments, hoping they were the correct size and had proper adapters this time. I quantified after amplification and had less yield than expected (<100ng) for all samples. Here is where I am confused and need some interpretations... I used the bioanalyzer with the HS DNA assay and got back the following electropherogram results. My input libraries seem ok and I think that the libraries are very diluted which is why it is a small peak. The other samples, my ChIP-DNA libraries, produced strange bioanalyzer readings. Please help me interpret these results.
    Attached Files
  • microgirl123
    Senior Member
    • Jun 2012
    • 199

    #2
    To start with your ladder looks bad - your ladder peaks should be as high as or higher than your marker peaks at the ends. Does your ladder always look like that? If so, I'd contact Agilent and if not, I'd run another chip. Either way, I wouldn't start worrying about the samples until you sort out the ladder.

    Comment

    • jlynn
      Junior Member
      • Nov 2015
      • 3

      #3
      Actually, since this is a unit in our shared core facility, for some reason the ladder was pretty much empty (<1ul). I had already set the chip up and then opened the ladder and said oh ****! So I added 5ul of 0.1% TE, vortexed, and loaded 1ul, which should explain the weak ladder. Do you think that it is worth doing another chip? Maybe with a less diluted library sample?

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      9 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      41 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Working...